Jane C. Burns

Jane C. Burns's AcademicInfluence.com Rankings

Jane C. Burns

Medical

#2094

World Rank

#2493

Historical Rank

Cardiology

#182

World Rank

#187

Historical Rank

Public Health

#301

World Rank

#313

Historical Rank

medical Degrees

Jane C. Burns

Philosophy

#6172

World Rank

#9166

Historical Rank

Logic

#3362

World Rank

#4509

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Jane C. Burns's Degrees

Doctorate Medicine University of California, San Francisco
Masters Public Health University of California, Berkeley

Why Is Jane C. Burns Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jane C. Burns's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Card (2007) (2635)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association (2017) (1887)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association (2004) (1523)
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. (2020) (1428)
Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. (1993) (1418)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association (2004) (1373)
The treatment of Kawasaki syndrome with intravenous gamma globulin. (1986) (1306)
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. (1991) (1082)
A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. (1994) (522)
The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL (2013) (500)
Generation of high-titer pseudotyped retroviral vectors with very broad host range. (1994) (480)
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms (2008) (415)
Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. (1998) (398)
Resistance to intravenous immunoglobulin in children with Kawasaki disease. (2008) (329)
Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. (2002) (326)
Sequelae of Kawasaki disease in adolescents and young adults. (1996) (325)
Recognition of a Kawasaki Disease Shock Syndrome (2009) (313)
ENDOTHELIAL CELL ACTIVATION AND HIGH INTERLEUKIN-1 SECRETION IN THE PATHOGENESIS OF ACUTE KAWASAKI DISEASE (1989) (300)
Kawasaki Disease. (2013) (299)
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease (2011) (292)
A Genome-Wide Association Study Identifies Novel and Functionally Related Susceptibility Loci for Kawasaki Disease (2009) (292)
Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish. (1994) (290)
A genome-wide association study identifies three new risk loci for Kawasaki disease (2012) (268)
Discovery and Characterization of Two Isoforms of Moronecidin, a Novel Antimicrobial Peptide from Hybrid Striped Bass* (2002) (254)
Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome (1986) (252)
Kawasaki Disease: A Brief History (2000) (230)
Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children. (2016) (227)
When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. (2009) (225)
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial (2014) (223)
Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. (2008) (209)
Kawasaki syndrome (2004) (196)
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. (1986) (181)
Transgenic cattle produced by reverse-transcribed gene transfer in oocytes. (1998) (179)
Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease (1991) (172)
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. (1987) (171)
Gamma globulin re-treatment in Kawasaki disease. (1993) (169)
Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan (2014) (167)
Infliximab treatment for refractory Kawasaki syndrome. (2005) (166)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease (2014) (161)
Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. (2020) (156)
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population (2016) (156)
Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. (2011) (156)
Seasonality and Temporal Clustering of Kawasaki Syndrome (2005) (152)
Organization and expression analysis of the zebrafish hepcidin gene, an antimicrobial peptide gene conserved among vertebrates. (2004) (147)
Association of Kawasaki disease with tropospheric wind patterns (2011) (146)
Seasonality of Kawasaki Disease: A Global Perspective (2013) (141)
Altered Lipid Profile After Kawasaki Syndrome (1991) (135)
Infectious hypodermal and hematopoietic necrosis virus of shrimp is related to mosquito brevidensoviruses. (2000) (131)
Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin. (1989) (125)
Prevalence of Kawasaki Disease in Young Adults With Suspected Myocardial Ischemia (2011) (123)
Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms. (1984) (120)
Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. (2012) (114)
Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease (2014) (107)
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. (1988) (105)
Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. (2005) (103)
The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease (2015) (103)
Transforming Growth Factor-&bgr; Signaling Pathway in Patients With Kawasaki Disease (2011) (98)
Increased Frequency of Alleles Associated with Elevated Tumor Necrosis Factor-α Levels in Children with Kawasaki Disease (2001) (97)
Image-based modeling of hemodynamics in coronary artery aneurysms caused by Kawasaki disease (2012) (96)
Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. (1992) (96)
Evolution of Laboratory Values in Patients With Kawasaki Disease (2011) (90)
Cerebrospinal fluid profile in patients with acute Kawasaki disease. (1998) (87)
Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic (2020) (87)
Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol. (1984) (87)
Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease (1986) (87)
Delayed Diagnosis by Physicians Contributes to the Development of Coronary Artery Aneurysms in Children With Kawasaki Syndrome (2007) (87)
Gene-expression patterns reveal underlying biological processes in Kawasaki disease (2007) (86)
Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998. (2000) (85)
High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease (2017) (83)
PRINCESS: Privacy‐protecting Rare disease International Network Collaboration via Encryption through Software guard extensionS (2017) (81)
Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease (2005) (80)
Human Coronavirus NL63 Is Not Detected in the Respiratory Tracts of Children with Acute Kawasaki Disease (2005) (79)
Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. (2013) (79)
Inositol-Triphosphate 3-Kinase C Mediates Inflammasome Activation and Treatment Response in Kawasaki Disease (2016) (79)
Commentary: translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967. (2002) (78)
Pantropic retroviral vectors integrate and express in cells of the malaria mosquito, Anopheles gambiae. (1996) (77)
miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease (2017) (77)
A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Endorsed by the American Academy of Pediatrics (2004) (76)
FAILURE TO DIAGNOSE KAWASAKI DISEASE AT THE EXTREMES OF THE PEDIATRIC AGE RANGE (2004) (75)
Kawasaki disease: late cardiovascular sequelae (2012) (74)
Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature (2018) (74)
Production of transgenic dwarf surfclams, Mulinia lateralis, with pantropic retroviral vectors. (1996) (74)
Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance. (2010) (73)
Anterior uveitis associated with Kawasaki syndrome (1985) (73)
Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease. (2013) (73)
Increased prevalence of atopic dermatitis in Kawasaki disease. (1988) (72)
Is Kawasaki disease incidence rising in Chandigarh, North India? (2010) (70)
Performance of 2004 American Heart Association Recommendations for Treatment of Kawasaki Disease (2010) (70)
Abnormal myocardial mechanics in Kawasaki disease: Rapid response to γ-globulin (2000) (69)
The riddle of Kawasaki disease. (2007) (69)
The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease. (2013) (68)
KAWASAKI SYNDROME: ASSOCIATION WITH THE APPLICATION OF RUG SHAMPOO (1982) (67)
Incidence of Kawasaki disease in northern European countries (2012) (67)
Treatment Response in Kawasaki Disease Is Associated with Sialylation Levels of Endogenous but Not Therapeutic Intravenous Immunoglobulin G (2013) (65)
Familial occurrence of Kawasaki syndrome in North America. (2005) (64)
Transplacental passage of influenza A/Bangkok (H3N2) mimicking amniotic fluid infection syndrome. (1984) (63)
Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. (2000) (63)
Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. (1991) (62)
Spatial and Temporal Clustering of Kawasaki Syndrome Cases (2008) (62)
Differential Expression of miR-145 in Children with Kawasaki Disease (2013) (61)
Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease (2014) (59)
Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial). (2016) (58)
Sensorineural hearing loss and Kawasaki disease: a prospective study. (2001) (57)
The Spectrum of Cardiovascular Lesions Requiring Intervention in Adults After Kawasaki Disease. (2016) (57)
Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease (2010) (56)
Kawasaki Disease and Human Coronavirus (2005) (56)
Specificity of regulatory T cells that modulate vascular inflammation (2014) (56)
A Simple Method for Assessment of Human Anti-Neu5Gc Antibodies Applied to Kawasaki Disease (2013) (56)
Psoriatic eruption in Kawasaki disease. (2000) (54)
Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis (2019) (54)
Molecular identification of viruses in sudden infant death associated with myocarditis and pericarditis. (1995) (53)
Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis (2019) (53)
Cardiovascular biomarkers in acute Kawasaki disease. (2013) (53)
Replication and Meta-Analysis of GWAS Identified Susceptibility Loci in Kawasaki Disease Confirm the Importance of B Lymphoid Tyrosine Kinase (BLK) in Disease Susceptibility (2013) (52)
Review: Found in Translation: International Initiatives Pursuing Interleukin‐1 Blockade for Treatment of Acute Kawasaki Disease (2017) (51)
Gamma globulin retreatment in Kawasaki disease (1992) (51)
Global epidemiology of vasculitis (2021) (50)
Pantropic retroviral vector-mediated gene transfer, integration, and expression in cultured newt limb cells. (1994) (50)
Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood. (1992) (49)
Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease (2011) (48)
Management of Kawasaki syndrome: a consensus statement prepared by North American participants of The Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1988 (1989) (48)
Adenovirus myocarditis: retrospective diagnosis by gene amplification from formalin-fixed, paraffin-embedded tissues. (1994) (47)
Elevated gamma-glutamyltransferase concentrations in patients with acute Kawasaki disease. (1998) (47)
Immune‐monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin (2013) (47)
Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population (2019) (46)
Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease. (1996) (45)
Kawasaki syndrome and the eye. (1989) (45)
Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. (2009) (45)
Audiologic profiles of children with Kawasaki disease. (1992) (44)
Acute myocardial ischemia in adults secondary to missed Kawasaki disease in childhood. (2014) (43)
Coronary Artery Dilation in Acute Kawasaki Disease and Acute Illnesses Associated With Fever (2012) (43)
Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease (2010) (43)
A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses (2011) (42)
Building a Natural Language Processing Tool to Identify Patients With High Clinical Suspicion for Kawasaki Disease from Emergency Department Notes. (2016) (42)
Kawasaki disease and cervical adenopathy. (1989) (42)
How Should We Classify Kawasaki Disease? (2018) (41)
Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10‐Year Experience (2018) (41)
Lifetime cardiovascular management of patients with previous Kawasaki disease (2019) (41)
Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications (2010) (41)
ADENOVIRUS, ADENO-ASSOCIATED VIRUS AND KAWASAKI DISEASE (2005) (40)
Pancreatic islet cell necrosis: association with hemolytic-uremic syndrome. (1982) (39)
Calcium scoring in patients with a history of Kawasaki disease. (2012) (39)
Pantropic retroviral vector integration, expression, and germline transmission in medaka (Oryzias latipes). (1997) (39)
Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated With Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities (2016) (38)
Adjunctive therapies for Kawasaki disease. (2016) (38)
Prospective comparison of culture vs genome detection for diagnosis of enteroviral meningitis in childhood. (1996) (38)
Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease (2019) (37)
Expression of foreign genes in primary cultured cells of the blue shrimp Penaeus stylirostris (2000) (36)
CROSS-REACTIVE NEUTRALIZING ANTIBODY AGAINST PANDEMIC 2009 H1N1 INFLUENZA A VIRUS IN INTRAVENOUS IMMUNOGLOBULIN PREPARATIONS (2011) (34)
Cardiovascular imaging in children and adults following Kawasaki disease (2015) (34)
Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis (2010) (34)
Transgenic Fish: Ideal Models for Basic Research and Biotechnological Applications (1995) (34)
Hemolymph analysis and evaluation of newly formulated media for culture of shrimp cells (Penaeus stylirostris) (2001) (33)
In Vitro Validation of Patient-Specific Hemodynamic Simulations in Coronary Aneurysms Caused by Kawasaki Disease (2014) (31)
Medium‐Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry (2020) (31)
Long-Term Management of Kawasaki Disease : A Statement for Health Professionals From the Committee on Rheumatic Fever , Endocarditis , and Kawasaki Disease , Council on Cardiovascular Disease in the (2004) (31)
Rethinking the Boundaries of Kawasaki Disease: Toward a Revised Case Definition (2003) (31)
Polymerase chain reaction for detection of measles virus in clinical samples (1993) (30)
PYURIA ASSOCIATED WITH ACUTE KAWASAKI DISEASE AND FEVER FROM OTHER CAUSES (2009) (30)
Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease (2018) (30)
Hemodynamic variables in aneurysms are associated with thrombotic risk in children with Kawasaki disease. (2019) (30)
Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood. (2015) (30)
Endoplasmic reticulum stress drives a regulatory phenotype in human T-cell clones. (2010) (30)
Impressions of Kawasaki syndrome in India. (2006) (29)
Quantitation of Adenovirus Genome During Acute Infection in Normal Children (2005) (28)
Association of CCR2-CCR5 Haplotypes and CCL3L1 Copy Number with Kawasaki Disease, Coronary Artery Lesions, and IVIG Responses in Japanese Children (2010) (28)
Decreased protein binding of salicylates in Kawasaki disease. (1991) (28)
Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins. (2012) (27)
Low plasma D-dimer concentration predicts the absence of traumatic brain injury in children. (2010) (27)
Passive surveillance for Kawasaki disease in San Diego County. (1997) (27)
Canine Pain Syndrome Is a Model for the Study of Kawasaki Disease (2015) (26)
The two emergencies of Kawasaki syndrome and the implications for the developing world. (2008) (26)
Reply to: “CCL3L1 and HIV/AIDS susceptibility” and “Experimental aspects of copy number variant assays at CCL3L1” (2009) (26)
Kawasaki Disease update (2009) (26)
PERIUNGUAL DESQUAMATION IN PATIENTS WITH KAWASAKI DISEASE (2009) (26)
Genetics insights into the pathogenesis of Kawasaki disease. (2012) (26)
Galectin-3 is a marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms. (2015) (25)
The HLA class II region and susceptibility to Kawasaki disease. (1992) (25)
Clustering and climate associations of Kawasaki Disease in San Diego County suggest environmental triggers (2018) (25)
Sensorineural hearing loss associated with Kawasaki disease. (1990) (24)
Pantropic retroviral vectors mediate somatic cell transformation and expression of foreign genes in dipteran insects (1998) (24)
Point-of-care differentiation of Kawasaki disease from other febrile illnesses. (2015) (24)
Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in kawasaki disease. (2003) (24)
Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease (2015) (24)
Lack of association between Kawasaki syndrome and Chlamydia pneumoniae infection: an investigation of a Kawasaki syndrome cluster in San Diego County. (2000) (23)
Kawasaki Disease in Monozygotic Twins (2011) (23)
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C (2022) (23)
Infection of cultured embryo cells of the pacific oyster, Crassostrea gigas, by pantropic retroviral vectors (2000) (23)
Recurrent Kawasaki disease-like syndrome in a patient with acquired immunodeficiency syndrome. (2003) (22)
Sensorineural hearing loss associated with Kawasaki disease (1992) (21)
Kawasaki Disease in India: Increasing Awareness or Increased Incidence? (2009) (21)
Psoriasiform eruptions during Kawasaki disease (KD): A distinct phenotype. (2016) (21)
Abstract O.29: Transcriptional Profiling Discriminates Complete and Incomplete KD from Human Adenovirus (2015) (21)
Computed Tomography Coronary Angiography for Evaluation of Children With Kawasaki Disease. (2017) (21)
Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles (2021) (21)
Kawasaki disease and ENSO‐driven wind circulation (2013) (21)
Pantropic retroviral vectors mediate gene transfer and expression in Entamoeba histolytica. (1999) (21)
Kawasaki disease Recent advances. (1995) (20)
Reply to: "Experimental aspects of copy number variant assays at CCL3L1". (2009) (20)
Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease (2018) (20)
Kawasaki Disease and Exposure to Fine Particulate Air Pollution. (2016) (20)
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease. (2019) (20)
An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease (2022) (20)
Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm. (2019) (20)
Kawasaki syndrome and house dust mite exposure (1986) (19)
Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease (2015) (19)
Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children (2016) (19)
Human Coronavirus-NL63 Infection is not Associated with Acute Kawasaki Disease (2006) (19)
The Narratives of Kawasaki Disease (2004) (19)
Role of TGF-β Signaling in Remodeling of Noncoronary Artery Aneurysms in Kawasaki Disease (2015) (18)
Usefulness of Calcium Scoring as a Screening Examination in Patients With a History of Kawasaki Disease. (2017) (18)
Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C. (2021) (18)
Circulating Markers of Inflammation Persist in Children and Adults With Giant Aneurysms After Kawasaki Disease (2019) (18)
Computational blood flow simulations in Kawasaki disease patients: Insight into coronary artery aneurysm hemodynamics (2017) (18)
Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness (2016) (17)
Characterization of a white bass (Morone chrysops) embryonic cell line with epithelial features (2003) (17)
History of the worldwide emergence of Kawasaki disease (2017) (17)
State-of-the-art basic and clinical science of Kawasaki disease (2008) (17)
Characterization of SARS‐CoV‐2 and common cold coronavirus‐specific T‐cell responses in MIS‐C and Kawasaki disease children (2021) (16)
Infection of lepidoptera with a pseudotyped retroviral vector. (1998) (16)
Assessment of Coronary Artery Aneurysms Caused by Kawasaki Disease Using Transluminal Attenuation Gradient Analysis of Computerized Tomography Angiograms. (2017) (15)
Patterns of Fever in Children After Primary Treatment for Kawasaki Disease (2015) (15)
Recurrent Fever Syndromes in Patients After Recovery From Kawasaki Syndrome (2011) (15)
Lipoprotein particle concentrations in children and adults following Kawasaki disease. (2014) (15)
Kawasaki disease: an essential comparison of coronary artery aneurysm criteria. (2018) (15)
Mistaken MIS-C: A Case Series of Bacterial Enteritis Mimicking MIS-C. (2021) (15)
3 – Extraction of Nucleic Acids: Sample Preparation from Paraffin-Embedded Tissues (1995) (14)
Pediatric tolerogenic DCs expressing CD4 and immunoglobulin‐like transcript receptor (ILT)‐4 secrete IL‐10 in response to Fc and adenosine (2018) (13)
Kawasaki disease: the mystery continues. (2002) (13)
Comparison of methods to detect enteroviral genome in frozen and fixed myocardium by polymerase chain reaction. (1994) (13)
Detection of novel RNA viruses: morbilliviruses as a model system. (1994) (13)
Plant Component Yield and Cell Contents of an Adapted and a Tropical Corn, Zea mays L.1 (1972) (12)
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial. (2021) (12)
Endothelial activation in the pathogenesis of Kawasaki disease. (1989) (12)
Characterization of trifluoroacetic acid hydrolyzed subtropical forage grass cell walls (1987) (12)
Biomarkers for the Discrimination of Acute Kawasaki Disease From Infections in Childhood (2020) (12)
Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility (2017) (12)
Prediction of Cell Wall Carbohydrates and Quality in Panicum Species by Near Infrared Reflectance Spectroscopy (1988) (12)
A Classification Tool for Differentiation of Kawasaki Disease from Other Febrile Illnesses. (2016) (11)
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children with Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial. (2020) (11)
Summary and Abstracts of the Sixth International Kawasaki Disease Symposium (2000) (11)
Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. (1986) (11)
Kawasaki disease (1999) (11)
Conjunctival biopsy in patients with Kawasaki disease. (1995) (11)
S100 proteins in the pathogenesis of Kawasaki disease. (2006) (11)
Characterization of circulating immune cells in acute Kawasaki disease suggests exposure to different antigens (2020) (10)
Warfarin plus Aspirin or Aspirin Alone for Patients with Giant Coronary Artery Aneurysms Secondary to Kawasaki Disease? (2014) (10)
Computational modeling of blood component transport related to coronary artery thrombosis in Kawasaki disease (2021) (10)
Rapid determination of cell wall monosaccharides in flaccidgrass (1986) (10)
Retroviral gene transfer inXenopus cell lines and embryos (1996) (10)
Management of Myocardial Infarction in Children with Giant Coronary Artery Aneurysms after Kawasaki Disease. (2020) (10)
Infliximab Pharmacokinetics are Influenced by Intravenous Immunoglobulin Administration in Patients with Kawasaki Disease (2018) (10)
Genome-wide linkage and association mapping identify susceptibility alleles in ABCC 4 for Kawasaki disease (2017) (10)
Increased Incidence and Severity of Kawasaki Disease Among Filipino-Americans in San Diego County (2011) (10)
Temporal Clusters of Kawasaki Disease Cases Share Distinct Phenotypes That Suggest Response to Diverse Triggers (2020) (9)
Safety of Infliximab Following Live Virus Vaccination in Kawasaki Disease Patients (2017) (9)
Seroprevalence of human herpesvirus 7 in patients with Kawasaki disease. (1994) (9)
Assessing vascular health after Kawasaki disease: a cautionary tale. (2013) (8)
High-Throughput Screening of Kawasaki Disease Sera for Antiviral Antibodies. (2020) (8)
Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction (2019) (8)
Management of sequelae of Kawasaki disease in adults (2017) (8)
Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C (2022) (8)
Revisiting steroids in the primary treatment of acute Kawasaki disease. (2006) (8)
Anakinra treatment in patients with acute Kawasaki disease with coronary artery aneurysms: A Phase I/IIa trial (2021) (7)
Evaluating a novel treatment for coronary artery inflammation in acute Kawasaki disease: a Phase I/IIa trial of atorvastatin (2015) (7)
Characterization of the Polymerase Activity Associated with Cultured Peripheral Blood Mononuclear Cells from Patients with Kawasaki Disease (1990) (7)
Letter by Daniels and Burns Regarding Article, "Incidence, Cause, and Comparative Frequency of Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A Decade in Review". (2016) (7)
GLC-MS analysis of the volatile constituents of Panicum sp. (1986) (7)
Inflammasome Activation in Children With Kawasaki Disease and Multisystem Inflammatory Syndrome. (2021) (7)
The histories of Kawasaki disease (2004) (7)
Hemicellulosic cell wall carbohydrate monomer composition in Panicum amarum, P. amarulum and P virgatum accessions (1992) (7)
Frequently asked questions regarding treatment of Kawasaki disease (2017) (6)
Digestible and Indigestible Cell Wall Carbohydrates of Flaccidgrass, Tall Fescue, and Coastal Bermudagrass 1 (1987) (6)
A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease (2016) (6)
A multidisciplinary approach to the treatment and management of chronic obstructive pulmonary disease (2008) (6)
Axillary, Oral and Rectal Routes of Temperature Measurement During Treatment of Acute Kawasaki Disease (2015) (6)
ASSOCIATION OF KAWASAKI SYNDROME WITH ATOPIC DERMATITIS (1987) (6)
Noninvasive Determination of Endothelial Cell Function in the Microcirculation in Kawasaki Syndrome (2007) (6)
Can insights into urodele limb regeneration be achieved with cell cultures and retroviruses? (1996) (6)
On the interpretation of the atmospheric mechanism transporting the environmental trigger of Kawasaki Disease (2019) (6)
Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease (2021) (5)
New perspectives on Kawasaki disease (2019) (5)
HLA-C variants associated with amino acid substitutions in the peptide binding groove influence susceptibility to Kawasaki disease. (2019) (5)
Hoarseness as a Presenting Sign in Children With Kawasaki Disease (2013) (5)
Reply -- The COVID-19 Pandemic, From Worrying About Missed or Delayed Diagnosis of Kawasaki Disease to the Flood of Multisystem Inflammatory Syndrome in Children (MIS-C) (2020) (5)
Pulmonary Artery Dilation and Right Ventricular Function in Acute Kawasaki Disease (2016) (5)
Young, American Heart Association Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Statement for Health Professionals From the Committee on Rheumatic Fever, Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A (2004) (4)
Clinical presentation of Kawasaki disease (1997) (4)
T Cells in Multisystem Inflammatory Syndrome in Children (MIS-C) Have a Predominant CD4+ T Helper Response to SARS-CoV-2 Peptides and Numerous Virus-Specific CD4− CD8− Double-Negative T Cells (2022) (4)
Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses (2016) (4)
Reporter Gene Expression in Fish Following Cutaneous Infection with Pantropic Retroviral Vectors (2001) (4)
Pantropic Retroviral Vectors for Insect Gene Transfer (2000) (4)
Cell Wall Carbohydrates of Flaccidgrass Plant Parts. I. Neutral Sugar Composition of Fermented Residues 1 (1987) (4)
New insights into cardiovascular disease in patients with Kawasaki disease (2018) (4)
Cell Wall Carbohydrates of Flaccidgrass Plant Parts. III. Near Infrared Reflectance Spectroscopy Determination, Rate, and Extent of Fermentation 1 (1987) (4)
Adjunctive testing in the evaluation of adults after Kawasaki disease. (2015) (3)
Cell Wall Carbohydrates of Flaccidgrass Plant Parts. II. Neutral Sugar Relationships to In Vitro Disappearance and Fiber Fractions 1 (1987) (3)
A New Definition for Multisystem Inflammatory Syndrome in Children. (2023) (3)
Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States (2022) (3)
Abstract 164: Thrombotic Risk Assessment in Kawasaki Disease Patients with Coronary Artery Aneurysms using Transluminal Attenuation Gradient Analysis (2015) (3)
Viral transducing vectors for mosquitoes (1997) (3)
Patient-Specific Hemodynamic Simulations in a Group of Patients With Coronary Artery Aneurysms Caused by Kawasaki Disease (2013) (3)
Kawasaki Disease: Do We Need a New Case Definition? (2003) (3)
Prolonged urticaria and fever in a toddler (2012) (3)
An AI-guided invariant signature places MIS-C with Kawasaki disease in a continuum of host immune responses. (2021) (3)
Intravenous immunoglobulin induces IgG internalization by tolerogenic myeloid dendritic cells that secrete IL-10 and expand Fc-specific regulatory T cells (2022) (3)
Of mice and children: lessons from a Kawasaki mouse model. (2012) (3)
Clinical Criteria for the Risk of Pediatric CAA in Historical Perspective (2003) (3)
Cyclosporine and coronary outcomes in Kawasaki disease. (2019) (3)
Bifid T waves on the ECG and genetic variation in calcium channel voltage‐dependent beta 2 subunit gene (CACNB2) in acute Kawasaki disease (2018) (3)
A machine-learning algorithm for diagnosis of multisystem inflammatory syndrome in children and Kawasaki disease in the USA: a retrospective model development and validation study (2022) (3)
IgG Epitopes Processed and Presented by IgG+ B Cells Induce Suppression by Human Thymic-Derived Regulatory T Cells (2021) (3)
Transient Lingual Papillitis Associated with Confirmed Herpes Simplex Virus 1 in a Patient with Kawasaki Disease (2014) (3)
Sensitivity of the Kawasaki Case Definition for Detecting Coronary Artery Abnormalities (2003) (3)
Comprar Kawasaki Disease. Current Understanding Of The Mechanism And Evidence-Based Treatment | Ben T. Saji | 9784431560371 | Springer (2016) (3)
Gene introduction into silkworm embryos with a pseudotyped retroviral vector (2000) (3)
Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades (2021) (3)
Autoantibodies Detected in MIS-C Patients due to Administration of Intravenous Immunoglobulin (2021) (3)
Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnesses (2020) (3)
Disease , Council on Cardiovascular Disease in the Young , American Heart for Health Professionals From the Committee on Rheumatic Fever , Endocarditis and Diagnosis , Treatment , and Long-Term Management of Kawasaki Disease : A Statement (2004) (3)
Temporal clustering of Kawasaki disease cases around the world (2021) (3)
An AI-guided signature reveals the nature of the shared proximal pathways of host immune response in MIS-C and Kawasaki disease (2021) (3)
Image-based modeling of hemodynamics in coronary artery aneurysms caused by Kawasaki disease (2011) (2)
Biomarkers of inflammation and fibrosis in young adults with history of Kawasaki disease (2021) (2)
Kawasaki syndrome. (1989) (2)
High risk of coronary artery aneurysms in infants younger than 6 months with Kawasaki disease (2017) (2)
Urotensin 2 in Kawasaki disease pathogenesis (2017) (2)
Finding Kawasaki disease (2012) (2)
Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq (2022) (2)
Extreme giant aneurysms of three coronary arteries causing heart failure as late sequelae of Kawasaki disease. (2016) (2)
Chronic hip pain and limp in a 3-year-old girl. (1989) (2)
Hyponatremia in Patients With Multisystem Inflammatory Syndrome in Children (2021) (2)
Reply (2020) (2)
Patient-Specific Hemodynamic Simulations in Coronary Artery Aneurysms Caused by Kawasaki Disease (2010) (2)
Kawasaki disease for the paediatric dermatologist: skin manifestations and new insights into the pathophysiology (2021) (2)
Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C (2022) (2)
Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seq (2022) (2)
Kawasaki’s Disease (2014) (1)
Late-sequalae of Kawasaki disease characterized by optical coherence tomography. (2020) (1)
ANTIGEN-SPECIFIC SECRETORY ANTIBODY (Ab) RESPONSE FOLLOWING RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN INFANTS (1984) (1)
Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis (2022) (1)
Author Correction: Clustering and climate associations of Kawasaki Disease in San Diego County suggest environmental triggers (2019) (1)
Abstract 189: Natural History of Coronary Artery Aneurysms in Kawasaki Disease in US population and Risk Factors for Persistent Aneurysms (2015) (1)
IL-1 and IL-6 inhibitor hypersensitivity link to common HLA-DRB1*15 alleles (2021) (1)
Multicenter Validation of a Machine Learning Algorithm for Diagnosing Pediatric Patients with Multisystem Inflammatory Syndrome and Kawasaki Disease (2022) (1)
Characterisation of immune complexes in Kawasaki Disease and other infectious diseases by protein sequencing (2019) (1)
Treatment of Kawasaki disease. (1992) (1)
Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study (2023) (1)
Publisher Correction: An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease (2022) (1)
Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease (2014) (1)
REVERSE TRANSCRIPTASE ACTIVITY (RTA) IN PERIPHERAL BLOOD MONONUCLEAR CELL (PBMC) CULTURES (CXS) FROM PATIENTS (PTS) WITH KAWASAKI DISEASE (KD) (1987) (1)
MIS-C: myths have been debunked, but mysteries remain (2023) (1)
Hypersensitivity reactions to IL-1 and IL-6 inhibitors are linked to common HLA-DRB1*15 alleles (2020) (1)
Single center blind testing of a US multi-center validated diagnostic algorithm for Kawasaki disease in Taiwan (2022) (1)
Abstract O.38: Fever Patterns in KD Patients after Treatment with IVIG (2015) (1)
In Vitro Validation of Patient-Specific Hemodynamic Simulations in Coronary Aneurysms Caused by Kawasaki Disease (2014) (1)
A Four-Year-Old with History of Kawasaki Disease Presenting in Acute Shock (2020) (1)
CFD-based Thrombotic Risk Assessment in Kawasaki Disease Patients with Coronary Artery Aneurysms (2012) (1)
The Climate–KD Link (2017) (1)
The risk of myocardial ischemia in patients with Kawasaki Disease: Insights from patient-specific simulations of coronary hemodynamics (2022) (1)
Abstract 11426: Biomarkers of Inflammation and Fibrosis in the Young Adults With History of Kawasaki Disease (2019) (1)
Coronary Artery Aneurysm Resolution after Kawasaki Disease (2022) (0)
372 NON-INVASIVE DETERMINATION OF ENDOTHELIAL CELL FUNCTION IN KAWASAKI DISEASE. (2004) (0)
Abstract 18858: Assessment of Coronary Artery Aneurysms Caused by Kawasaki Disease Using Transluminal Attenuation Gradient Analysis of Coronary CT Angiograms (2015) (0)
Abstract 167: CT Calcium Scoring Detects Coronary Artery Pathology In Patients With A Remote History Of Kawasaki Disease (2015) (0)
Pulsed corticosteroids of no benefit in Kawasaki disease. (2007) (0)
An Online Delphi Consensus Panel for Prioritizing Person-Centered Outcomes Research Topics (2016) (0)
Clustering of KD samples on the basis of intrinsic gene-expression patterns (2011) (0)
Abstract 12251: Galectin-3 as a Predictor of Myocardial Fibrosis in Kawasaki Disease (2014) (0)
Patterns of transcript abundance as a function of illness day (days post-onset of fever) (2011) (0)
and the Quality of Care and Cardiovascular Disease in the Young, the on Clinical Cardiology, Endocarditis, and on Association. A Guideline From the American Heart Association Rheumatic Prevention of Infective Endocarditis. Guidelines From the American Heart (2007) (0)
Creation of a Molluscan Cell Line (2003) (0)
Gene-expression patterns reveal underlying biological processes inKawasaki disease (2007) (0)
Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease (2014) (0)
CHARACTERISTICS OF CORONARY ARTERY ANEURYSMS CAUSED BY ATHEROSCLEROSIS VERSUS KAWASAKI DISEASE (2018) (0)
Microarray analysis of ST6GAL1 transcript. (2013) (0)
Abstract O.17: Whole Genome Sequencing of a six-member African American family with two Kawasaki disease-affected siblings identifies novel susceptibility variants (2015) (0)
Abstract O.32: An Improved Point-of-care Differentiation Of Kawasaki Disease From Other Febrile Illnesses (2015) (0)
Bridging a diagnostic Kawasaki disease classifier from a microarray platform to a qRT-PCR assay (2022) (0)
Altered Lipid Profile After Kawasaki Syndrome 627 (2005) (0)
Kawasaki Disease: Management and Future Directions (2015) (0)
Creation of a Molluscan Cell Line - eScholarship (2003) (0)
Implementation of KIDMATCH: A Clinical Decision Support Tool for Diagnosing Pediatric Patients with Multisystem Inflammatory Syndrome and Kawasaki Disease (2022) (0)
Intravenous immunoglobulin resistance in Kawasaki disease patients: prediction using clinical data (2023) (0)
1449: CLINICAL COMPARISON OF KAWASAKI DISEASE SHOCK SYNDROME AND SEPTIC SHOCK IN THE PICU (2016) (0)
Abstract 2957: New AHA Recommendations Improve Recognition and Treatment of Kawasaki Disease: A Multicenter Retrospective Review of Patients With Coronary Aneurysms. (2007) (0)
Finding Kawasaki Disease. (2017) (0)
Association of transcript abundance and clinical parameters in patients with acute KD (cohort 2) (2011) (0)
Abstract O.16: Comprehensive Genotyping Of The FCGR2/3 Locus Reveals A Novel Association Of FCGR2C-ORF With Susceptibility To Kawasaki Disease (2015) (0)
Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with disease. (2016) (0)
299 – Kawasaki Disease (2015) (0)
A Low Quantitative D-Dimer Concentration Predicts the Absence of Traumatic Brain Injury in Children. (2009) (0)
Exercise Stress Echocardiography in Kawasaki Disease Patients with Coronary Aneurysms (2022) (0)
Abstract O.19: Fine Specificity Of Natural Regulatory T Cells That Modulate Vascular Inflammation (2015) (0)
Revisiting Once Again Steroids for the Treatment of Acute Kawasaki Disease (2020) (0)
Abstract O.46: A Phase I/IIa Dose Escalating, Open-label Study of Atorvastatin in Children with Acute Kawasaki Disease and Coronary Artery Abnormalities (2015) (0)
Genetic Polymorphisms in the Regulatory Region of the TNF-α Gene in Children with Kawasaki Disease (1999) (0)
Abstract O.72: The Spectrum Of Cardiovascular Lesions Requiring Intervention In Young Adults After Kawasaki Disease (2015) (0)
P2634Studies on missed Kawasaki disease in developing countries (2018) (0)
168. Kawasaki Disease (2011) (0)
Reply to Dr. Dahdah’s Letter to the Editor Re: “A Four-Year-Old with History of Kawasaki Disease Presenting in Acute Shock” (2020) (0)
Letter by Daniels et al regarding article, "Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age". (2013) (0)
Characterization of the T Cell Response to Lactobacillus casei Cell Wall Extract in Children With Kawasaki Disease and Its Potential Role in Vascular Inflammation (2021) (0)
Abstract 14700: Atorvastatin Safety and Pharmacokinetics in Acute Kawasaki Disease Patients With Coronary Artery Abnormalities (2017) (0)
Kawasaki Disease: A Climate Connection? (2003) (0)
Abstract O.23: Lysyl Oxidase Expression In The Patients With Kawasaki Disease (2015) (0)
MICRORNA-483 TARGETING CONNECTIVE TISSUE GROWTH FACTOR: IMPLICATION IN KAWASAKI DISEASE (2015) (0)
Abstract 18975: Patient Centered Outcomes Research Priorities for Heart Failure and Kawasaki Disease: An Online Consensus Panel of Patients, Clinicians, and Researchers (2017) (0)
Education, concentration and more efficient transfer of retroviral vectors pseudotyped vsv-g (1994) (0)
Kawasaki-like Syndrome in an Adult AIDS Patient (2003) (0)
Hemodynamic Based Coronary Artery Aneurysm Thrombosis Risk Stratification in Kawasaki Disease Patients (2017) (0)
Abstract 2790: Angiotensin Converting Enzyme and {beta}3-Integrin Influence Susceptibility to Kawasaki Disease (2006) (0)
Kawasaki Disease Patient Stratification and Pathway Analysis Based on Host Transcriptomic and Proteomic Profiles (2021) (0)
Long-term health outcomes in young adults after Kawasaki disease (2022) (0)
Author Correction: Clustering and climate associations of Kawasaki Disease in San Diego County suggest environmental triggers (2019) (0)
Abstract 161: Investigating the Added Value Of Repeated ECHO Imaging In Patients With Kawasaki Disease and Always-Normal Coronary Arteries (2015) (0)
Guaranteeing the Volume Guarantee Ventilation (2015) (0)
Final Report: Toward the genetic engineering of disease resistance in oysters SeaGrant -112 Test methods of introducing pantropic vectors into embryos (2004) (0)
CULTURE OF SHRIMP CELLS (PENAEUS STYLIROSTRIS) (2001) (0)
118Transcriptional Profiling Discriminates Complete and Incomplete Kawasaki Disease (KD) from Adenovirus infection (HAdV) (2014) (0)
Pharmacokinetic and Safety Evaluation of a Pediatric Formulation of Pentoxifylline for Treatment of Acute Kawasaki Disease (2003) (0)
Kawasaki Disease: Epidemiology, Etiology, Biomarkers (2015) (0)
Comprehensive genotyping of the FCGR2/3 locus reveals a novel association of FCGR2C- ORF with susceptibility to Kawasaki Disease as well as extensive ethnic variation and linkage disequilibrium (2017) (0)
Title Lipoprotein Particle Concentrations in Children and Adults following Kawasaki Disease Permalink (2014) (0)
ROLE OF HOUSE DUST MITES IN KAWASAKI SYNDROME (KS) (1984) (0)
Comparing Treatments for Resistant Kawasaki Disease – The KIDCARE Study (2023) (0)
Title Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease Permalink (2014) (0)
PRIMARY TREATMENT INTENSIFICATION WITH STEROIDS VERSUS INFLIXIMAB IN PATIENTS WITH CORONARY ARTERY ANEURYSMS AT TIME OF DIAGNOSIS (2018) (0)
Future Directions in Kawasaki Disease Research (2017) (0)
160 – Kawasaki disease (2015) (0)
Comparison of Normal and Pathological Hemodynamics in Coronary Artery Aneurysms Caused by Kawasaki Disease (2011) (0)
RNA Sequencing Reveals Beneficial Effects of Atorvastatin on Endothelial Cells in Acute Kawasaki Disease (2022) (0)
Abstract 16234: Galectin-3 Levels in Young Adults With a History of Kawasaki Disease (2013) (0)
OF THE WEEK Kawasaki Disease (2016) (0)
Clustering and climate associations of Kawasaki Disease in San Diego County suggest environmental triggers (2018) (0)
Rethinking the Boundaries (2003) (0)
Antibody response and antigenic variation in the long (RSV-L) and 18537 strains of respiratory syncytial virus (RSV)- (1985) (0)
UC San Diego UC San Diego Previously Published Works Title Adjunctive therapies for Kawasaki disease (2016) (0)
Association of Acute Anti-Inflammatory Treatment with Medium-Term Outcomes for Coronary Artery Aneurysms in Kawasaki Disease (2022) (0)
Kawasaki Disease and Tropospheric Wind Patterns (2013) (0)
Abstract 188: Carotid Artery Strain in Young Adults with a History of Kawasaki Disease (2015) (0)
A functional polymorphism in ITPK(C) and its impact in T cell‐mediated pathogenesis of Kawasaki disease (2008) (0)
Transluminal Attenuation Gradient for Thrombotic Risk Assessment in Kawasaki Disease Patients with Coronary Artery Aneurysms (2014) (0)
Title Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease Permalink (2018) (0)
Title Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease Permalink (2016) (0)
Patterns of transcript abundance in whole-blood samples from children with KD (cohort 1) (2011) (0)
Methods for producing high titer, pantropic retroviral vectors for gene transfer into leukemic T-cells. (1997) (0)
OP0197 High-Resolution, Integrated Molecular Profiling Reveals Persistent Inflammation in Kawasaki Disease Patients with Coronary Artery Aneurysms (2015) (0)
Human natural regulatory T cells recognize peptides of the heavy constant region of immunoglobulins presented by IgG+ B cells (2019) (0)
283 INCREASING RATE OF INTRAVENOUS IMMUNOGLOBULIN NONRESPONDERS AMONG CHILDREN WITH ACUTE KAWASAKI SYNDROME IN SAN DIEGO COUNTY. (2007) (0)
Incidence and Severity of Kawasaki Disease Among Vietnamese Children (2022) (0)
Unbiased Screening of Kawasaki Disease Sera for Viral Antigen Exposure (2017) (0)
Erratum: Transforming growth factor-β signaling pathway in patients with Kawasaki disease (Circulation: Cardiovascular Genetics (2011) 4 (16-25)) (2011) (0)
Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications (2011) (0)
Summary of the 8 th International Kawasaki Disease Symposium: Presentation of Selected Abstracts (2008) (0)
TOPIC OF THE WEEK Kawasaki Disease (2016) (0)
Levels of mRNA in pretreatment whole-blood samples from KD patients who subsequently responded (R) o (2011) (0)
Mechanisms for Altering Cell Wall Utilization—Session Synopsis (1993) (0)
Endothelial Biomedicine: Kawasaki Disease (2007) (0)
Kawasaki disease. (2001) (0)
Abstract 47: Expression of Galectin-3 in the Myocardium and Arterial Walls of Kawasaki Disease Patients (2015) (0)
Title Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin Permalink (2013) (0)
Pharmacokinetic and Safety Evaluation of a Pediatric Formulation of Pentoxifylline for Treatment of Acute Kawasaki Disease (2003) (0)
Transcript abundance patterns in Kawasaki disease patients with IVIG resistance (2010) (0)
Abstract 16981: Innate Immune Activation and Endothelial Cell Dysfunction in Acute Kawasaki Disease (2017) (0)
Predictors of Myocardial Ischemia in Patients with Kawasaki Disease: Insights from Patient-Specific Simulations of Coronary Hemodynamics. (2023) (0)
Title A Classification Tool for Differentiation of Kawasaki Disease from Other Febrile Illnesses Permalink (2016) (0)
Foreword to the Special Issue (2017) (0)
Hemodynamic simulations in coronary aneurysms of children with Kawasaki disease (2009) (0)
Canine pain syndrome: A model for Kawasaki disease (1992) (0)
Abstract 476: Kawasaki Disease, Metabolic Switch, And Endothelial Dysfunction (2022) (0)
Abstract 4: Analysis of West Coast Atmospheric Circulation Patterns and Kawasaki Disease “Dry Spells” (2015) (0)
Toward the genetic engineering of disease resistance in oysters (2003) (0)
736: A COMPARISON OF PEDIATRIC ICU PRESENTATION OF MIS-C, KAWASAKI DISEASE, TOXIC SHOCK, AND SEPTIC SHOCK (2022) (0)
Genetic Variants in HLA-C and Class I Pathway Genes Influence Susceptibility to Kawasaki Disease (2017) (0)
Putting Out the Fire in Acute Kawasaki Disease. (2018) (0)
Assessing Vascular Health After Kawasaki Disease (2013) (0)
Treatment of Kawasaski Disease- Beyond IVIG (2017) (0)
Lipid Peroxidation and Kawasaki Disease (2003) (0)
Assessment Of Coronary Artery Aneurysms Using Transluminal Attenuation Gradient And Computational Modeling In Kawasaki Disease Patients (2015) (0)
Psoriatic rash in Kawasaki disease (1992) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jane C. Burns?

Jane C. Burns is affiliated with the following schools:

University of California, San Diego

Jane C. Burns's Academic­Influence.com Rankings

Jane C. Burns's Degrees

Why Is Jane C. Burns Influential?

Jane C. Burns's Published Works

Published Works

What Schools Are Affiliated With Jane C. Burns?

Jane C. Burns's AcademicInfluence.com Rankings